Proposal to list medical devices supplied by Toomac Holdings Limited
What we’re proposing
Pharmac is seeking feedback on a proposal to list a range medical devices supplied by Toomac Holdings Limited (“Toomac”) in Part III of Section H of the Pharmaceutical Schedule from 1 July 2025 in the following categories
- patient assessment, monitoring and treatment
- surgical implants
- medical and surgical instruments and power tools
Consultation closes at 4pm, Wednesday 28 May 2025 and feedback can be emailed to shannen.lo@pharmac.govt.nz
What would the effect be?
From 1 July 2025, Toomac’s range of medical devices in the patient assessment, monitoring and treatment, surgical implants, and medical and surgical instruments and power tools categories would be listed in the Pharmaceutical Schedule under a national agreement for all Health New Zealand | Te Whatu Ora (“Health NZ”) hospitals to purchase under, subject to consultation and approval by Pharmac’s Board or delegate.
The agreement would not be for sole supply and Health NZ hospitals can continue to purchase other suppliers’ brands of medical devices in the categories listed above.
The agreement would supersede any existing Health NZ contracts with Toomac for the medical devices included in the agreement. Any medical device listed in the agreement, and purchased by a Health NZ hospital, would be in accordance with the terms and conditions, including price, stated in the agreement effective from the date of listing in the Pharmaceutical Schedule.
Pricing for medical devices in the agreement, subject to any prior termination of the agreement, would not be increased without prior consultation and approval by Pharmac.
Who we think will be interested
- Health NZ staff including but not limited to the following areas:
- Audiologists
- Clinical engineers and maintenance services
- Clinical Product Coordinators
- Dermatologists
- ENT clinicians
- Gastroenterologists
- ICU, emergency, and critical care staff
- Neurologists and Neurosurgeons
- Neurosciences
- Nurses
- Ophthalmologists
- Patient Monitoring
- Perioperative staff
- Procurement and supply chain personnel
- Psychologists
- Somnology
- Sterile services personnel
- Surgeons
- Surgical and general ward staff
- Urologists
- Vascular medicine clinicians
- Wards and outpatient clinics
- Suppliers and wholesalers
About these products
Patient assessment, monitoring and treatment devices include equipment and consumable medical devices that are used in a variety of clinical settings to assess, monitor and treat patients. Clinical areas of use include Audiology, Ear, Nose and Throat (ENT), Dermatology, Gastroenterology, Neurosciences and Psychology, Ophthalmology, Somnology, Urology, Vascular Medicine, Wards and Outpatient Clinics.
Surgical implants are devices that are placed in or on the body. These devices support a range of functions, such as replacing damaged tissue, supporting existing tissue or enhancing existing bodily functions. The surgical implants encompass product ranges of reconstructive implants, surgical stents, orthopaedic soft tissue fixation, surgical mesh, ocular implants, aural implants and implantable neurostimulators.
Medical and surgical instruments and power tool products are used in a vast range of medical and surgical specialities and procedures. Some are more generally used within clinical practice and others have highly specific applications. Some require power sources or other equipment to perform their function.
Why we’re proposing this
Pharmac issued a Request for Proposal (“RFP”) in:
- 2018 for multi-category patient assessment, monitoring and treatment equipment and consumables
- 2021 for surgical implants, medical and surgical instruments and power tools, and associated products.
These RFPs were for non-exclusive national agreements for listing on the Pharmaceutical Schedule.
Pharmac has been working with suppliers who responded to the RFPs, and were successful in being progressed to contract negotiation, to seek provisional agreements. This proposal is the latest to arise from these processes.
Details about our proposal
The proposal would result in 1,308 medical devices being listed in the Pharmaceutical Schedule covering the following brands:
|
Category |
Number of Devices |
Brands |
|---|---|---|
|
Patient Assessment, Monitoring and Treatment |
197 |
Bausch & Lomb, DGH Technology Inc, Haag Streit UK, Haag Streit AG Diagnostics |
|
Surgical Implants |
913 |
Bausch & Lomb |
|
Medical and Surgical Instruments and Power Tools |
198 |
E. Janach s.r.l, Haag Streit UK |
Further information, including pricing and contractual details, has been provided to Health NZ procurement personnel. Clinicians interested in further detail on what the proposal means for their hospital should engage with the procurement team.
To provide feedback
Send us an email: shannen.lo@pharmac.govt.nz 4pm, Wednesday 28 May 2025
All feedback received before the closing date will be considered by Pharmac’s Board (or its delegate) prior to making a decision on this proposal.
Your feedback may be shared
When you give feedback on a consultation, your feedback becomes official information that Pharmac holds. Pharmac has legal responsibilities for how we manage this official information, under laws such as the Official Information Act and Privacy Act.
Pharmac may receive a request from people for official information, which could include your feedback. Legally, Pharmac must consider whether your feedback should be released.
We will consider your views when assessing whether the feedback has to be released. Tell us if there is anything about your feedback that you would prefer wasn’t released.
If your feedback is proposed for release, then Pharmac will contact you, unless there is a legal reason that we can't.
Note that Pharmac collects and holds your information in line with our Privacy Statement.